|
CDC Acute Flaccid Myelitis Task Force
|
Committee, Work group, Advisory group, or Task Force
|
CDC
|
NINDS, NIAID
|
The AFM Task Force was established to aid in the ongoing investigation to define the cause of, and improve treatment and outcomes for, patients with AFM. The Task Force functions as a work group of the CDC Board of Scientific Counselors, Deputy Director for Infectious Diseases.
|
|
CDC Integration with GrantSolutions
|
Resource Development
|
ACF, CDC
|
OD/OER
|
Collaboration with GrantSolutions to allow the Centers for Disease Control and Prevention (CDC) Research programs to seamlessly use electronic Research Administration (eRA) research grant support services, including the eRA Commons grantee portal and the eRA Peer Review suite while having grants management staff process awards within GrantSolutions.
|
|
CDC Office of Public Health Genomics
|
Public Education Campaign
|
CDC
|
NHLBI
|
This collaboration seeks to define and implement a translational trajectory for scientific discoveries in genomics and related fields to population health benefits in health areas relevant to National Heart, Lung, and Blood Institute (NHLBI) including, heart, lung, blood, and sleep disorders.
|
|
CDC Pathogen Genomic Centers of Excellence (PGCoE)
|
Research Initiative
|
CDC
|
NIAID
|
The PGCoE network is intended to foster and improve innovation and technical capacity in pathogen genomics, molecular epidemiology, and bioinformatics to better prevent, control. and respond to microbial threats of public health importance.
|
|
CDC-NIH Lyme Disease Serum Sample Repository
|
Resource Development
|
CDC, OS
|
NIAID
|
Initiated in 2008, this resource was made available to the scientific community on a broad basis in late 2011. Lyme disease and related serum samples are available upon request for testing and comparison of new and current diagnostic tests with a common serum sample set for standardization. Samples are distributed by the Centers for Disease Control and Prevention (CDC). CDC and National Institutes of Health (NIH) both provided support to acquire the samples and continue to work together to ensure the scientific community has access to samples needed for Lyme disease diagnostic test development.
|
|
CDC/NIH Quarterly Check-ins
|
Other
|
CDC
|
OD/DPCPSI/OAR, NIMH, NIAID
|
Regularly scheduled calls between CDC and NIH to share high level information, administrative updates, and upcoming initiatives related to HIV research.
|
|
Cell-Surface Interactions in Pathogenesis
|
Research Initiative
|
FDA
|
NIDCR
|
Cell-Surface Interactions in Pathogenesis
|
|
Center for Medicare and Medicaid Services (CMS) and National Institutes of Health (NIH) Opioids Work Group (OWG)
|
Committee, Work group, Advisory group, or Task Force
|
CMS
|
NIDA, NCCIH, NINDS, NIMH
|
With focused participation from both the Centers for Medicare and Medicaid Services (CMS) and experts across the National Institutes of Health (NIH), the Opioids Work Group (OWG) is designed to accelerate collaboration between these two HHS Operating Divisions related to addressing the U.S. opioid crisis.
|
|
Central Brain Tumor Registry of the United States (CBTRUS)
|
Research Initiative
|
CDC
|
NCI
|
CBTRUS is a resource for gathering and disseminating epidemiologic data on primary benign and malignant brain and other CNS tumors- Dr. Barnholtz-Sloan and her research team work with the CBTRUS team on a variety of research topics related to the epidemiology of brain tumors.
|
|
Cervical screening guidelines
|
Resource Development
|
CDC, HRSA, FDA
|
NCI
|
The National Cancer Institute (NCI) is generating risk estimates that inform cervical screening and management guidelines. NCI is working with CDC, HRSA, and FDA to collect study populations, conduct risk estimation, and disseminate guidelines.
|